CDH2 and prostate cancer: Interestingly, our findings showed that down regulation of NR6A1 protein expression significantly increased E-cadherin expression, and markedly reduced N-cadherin, Vimentin and ZEB-1 expression in prostate cancer cells (DU145 and PC3), while overexpression of NR6A1 hold the opposite effects.